Searched for
PSORIATIC ARTHRITIS TREATMENT
Psoriatic Arthritis explained: Early signs, causes, and how to stop joint damage before it startsPsoriatic arthritis affects skin and joints with inflammation. This autoimmune condition causes pain, stiffness, and swelling. Early detect...21 Oct, 2025, 05.57 PM IST- Biocon Biologics launches product for autoimmune diseases in AustraliaBiocon's subsidiary, Biocon Biologics, has introduced Nepexto, a biosimilar to Enbrel (Etanercept), in Australia for treating autoimmune di...23 Jul, 2025, 12.20 PM IST
- Lupin signs $50 million licensing deal with Zentiva to commercialise Certolizumab Pegol across global marketsLupin Ltd has partnered with Zentiva Group to commercialize its biosimilar 'Certolizumab Pegol' across global markets. The agreement grants...09 Jul, 2025, 03.32 PM IST
- Biocon Biologics secures multiple market access agreements in US for YesintekBiocon Biologics' Yesintek, a biosimilar to Stelara, has secured significant market access in the US, covering over 100 million lives. Mult...05 May, 2025, 10.38 AM IST
- Biocon settles with Janssen to commercialise biosimilar products in Europe, Canada, JapanBiocon Biologics has entered into a settlement and licence agreement with Janssen Biotech Inc, Janssen Sciences Ireland, and Johnson & John...29 Aug, 2024, 11.36 AM IST
- Eli Lilly forays into dermatological space with launch of psoriasis drugEli Lilly has launched a new drug to treat moderate-to-severe plaque psoriasis in India. The drug, Copellor, is designed to specifically ta...14 Mar, 2023, 12.18 PM IST
- Biocon Biologics inks out-licensing agreement with Yoshindo IncUnder the terms of this deal, Japan-based Yoshindo gets exclusive commercialisation rights in Japan for Ustekinumab and Denosumab -- develo...17 Oct, 2022, 11.00 AM IST
- Shilpa Medicare gets tentative American health regulator nod for Apremilast tabletsThe company has received tentative approval from US Food and Drug Administration for its abbreviated new drug application (ANDA) Apremilast...05 Mar, 2021, 11.50 AM IST
- World Autoimmune Arthritis Day: Don't let pain dominate your life. Early treatment, lifestyle changes are keyRheumatoid arthritis affects about 1 in 100 Indians.20 May, 2020, 11.16 AM IST
- Don't ignore joint pain with fever, fatigue: It can mean rheumatoid arthritisRheumatoid arthritis, an autoimmune disease, tends to affect women more than men.12 Oct, 2018, 10.26 AM IST
- Lupin, Nichi-Iko tie up for commercialization of biosimilar Etanercept in JapanMumbai based Lupin pharma and Japan's Nichi-Iko have tied up for the distribution, promotion and sale of Lupin’s recently-filed biosimilar ...18 Jun, 2018, 11.59 AM IST
- Torrent Pharma launches Adalimumab biosimilar in IndiaThe company's product will be available as pre-filled syringe of 40 mg, Torrent Pharmaceuticals said in a statement.12 Jan, 2016, 02.19 PM IST
- Zydus Cadila launches biosimilar of AbbVie's Humira in IndiaZydus Cadila today launched biosimilar of Adalimumab, used for treatment of auto immune disorders, at a price much lower than the innovator...09 Dec, 2014, 03.12 PM IST
- Ranbaxy launches arthritis drug Infimab in IndiaInfimab has been introduced in the Indian market through a licensing partnership with Epirus Biopharmaceuticals, Ranbaxy said in a statemen...01 Dec, 2014, 05.17 PM IST
- Cipla launches biosimilar for rheumatic disorders in IndiaDrug major Cipla said it has launched biosimilar of Etanercept under the brand name 'Etacept' used for treatment of rheumatic disorders in ...17 Apr, 2013, 12.57 PM IST
- Strides Arcolab's arm Onco Therapies gets USFDA nod for cancer drug Methotrexate InjectionStrides Arcolab today said its subsidiary Onco Therapies received the US drug regulator's nod to sell cancer medicine Methotrexate Injectio...30 Mar, 2012, 06.33 PM IST
- Now, a golden cure for arthritisInjecting gold into knees affected by osteoarthritis may ease pain and slow down the progress of the disease, but scientists say it does no...12 Oct, 2006, 12.00 AM IST
Load More
